Antiviral phosphoramidates
US7608599B2 · kind B2 · utility
64Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2006 |
| Grant date | Oct 27, 2009 |
| Priority date | — |
| Expiry date | Apr 30, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides novel nucleoside compounds of formula I wherein R1, R2a, R2b, R3, R4, R5 R6, R8a, R9 and R10 are as defined herein which are useful for the treatment of Hepatitis C Virus (HCV) mediated diseases. The invention further provides methods for treatment or prophylaxis of HCV mediated diseases with compounds of formula I and pharmaceutical compositions comprising these compounds,
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.